Allopurinol
- Product NDC
- 68071-4131
- 11-digit product format
- 680714131
- Labeler code
- 68071
- Product ID
- 68071-4131_5c7819eb-2bce-fc25-e053-2991aa0af451
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- NDA018832
- Marketing category
- NDA
- Marketing start
- 2009-04-06
- Marketing end
- 0000-00-00
- Substance
- ALLOPURINOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4131-3 | 2021-04-21 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |
| 68071-4131-6 | 2021-04-21 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |
| 68071-4131-9 | 2021-04-21 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |
| 68071-4131-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |
| 68071-4131-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |
| 68071-4131-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3726-a910-e053-dadaa90a0b85 | 5c783ef1-17e7-d881-e053-2a91aa0a08b1 |